Biomet Victory In Patent Suit Appeal Boosts Stock Nearly 30% In September
This article was originally published in The Gray Sheet
Executive Summary
Victory in a patent suit appeal striking down a 1996 jury award of about $37 mil. helped propel Biomet stock ahead 29.1% in September. The issue closed the month at 34-11/16, an advance of 7-13/16 points.